Phentolamine for vasodilator treatment of severe heart-failure.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000328:Adult; D006321:Heart / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006352:Heart Ventricles / Q000187:drug effects / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D007275:Injections, Intravenous; D007511:Ischemia / Q000150:complications; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D010646:Phentolamine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013902:Radiography, Thoracic; D012119:Respiration / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D014665:Vasodilator Agents; D010646:Phentolamine